Kendall Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.01M Sell
26,964
-626
-2% -$116K 1.32% 18
2025
Q1
$5.78M Sell
27,590
-2,557
-8% -$536K 1.7% 11
2024
Q4
$5.36M Sell
30,147
-1,905
-6% -$339K 1.57% 13
2024
Q3
$6.33M Sell
32,052
-675
-2% -$133K 1.95% 8
2024
Q2
$5.61M Sell
32,727
-126
-0.4% -$21.6K 1.87% 9
2024
Q1
$5.98M Sell
32,853
-615
-2% -$112K 2.06% 6
2023
Q4
$5.19M Buy
33,468
+1,033
+3% +$160K 2.01% 6
2023
Q3
$4.84M Buy
32,435
+195
+0.6% +$29.1K 2.14% 6
2023
Q2
$4.34M Buy
32,240
+731
+2% +$98.5K 1.9% 7
2023
Q1
$5.02M Buy
31,509
+347
+1% +$55.3K 2.41% 5
2022
Q4
$5.04M Sell
31,162
-947
-3% -$153K 2.54% 5
2022
Q3
$4.31M Sell
32,109
-370
-1% -$49.7K 2.51% 4
2022
Q2
$4.97M Sell
32,479
-845
-3% -$129K 2.74% 3
2022
Q1
$5.4M Sell
33,324
-1,815
-5% -$294K 2.61% 5
2021
Q4
$4.76M Sell
35,139
-796
-2% -$108K 2.26% 7
2021
Q3
$3.88M Sell
35,935
-930
-3% -$100K 2.1% 9
2021
Q2
$4.15M Sell
36,865
-635
-2% -$71.5K 2.33% 7
2021
Q1
$4.06M Buy
37,500
+310
+0.8% +$33.5K 2.51% 7
2020
Q4
$3.99M Sell
37,190
-335
-0.9% -$35.9K 2.91% 4
2020
Q3
$3.29M Buy
37,525
+870
+2% +$76.2K 2.86% 4
2020
Q2
$3.6M Buy
36,655
+3,575
+11% +$351K 3.45% 2
2020
Q1
$2.52M Sell
33,080
-2,906
-8% -$221K 2.85% 4
2019
Q4
$3.19M Buy
35,986
+1,022
+3% +$90.5K 2.51% 4
2019
Q3
$2.65M Buy
34,964
+2,570
+8% +$195K 2.34% 5
2019
Q2
$2.36M Buy
32,394
+878
+3% +$63.9K 2.13% 7
2019
Q1
$2.54M Buy
31,516
+1,345
+4% +$108K 2.41% 6
2018
Q4
$2.78M Sell
30,171
-483
-2% -$44.5K 2.88% 3
2018
Q3
$2.9M Buy
30,654
+1,963
+7% +$186K 2.47% 6
2018
Q2
$2.66M Buy
28,691
+965
+3% +$89.4K 2.35% 7
2018
Q1
$2.62M Sell
27,726
-85
-0.3% -$8.04K 2.27% 7
2017
Q4
$2.69M Buy
+27,811
New +$2.69M 2.39% 7